“…This method has been previously established in clinical studies of schizophrenia and autism and to examine power changes in those disorders. To evaluate the state of SNR in this model, baseline, evoked and total power were examined in high and low frequency ranges to determine if these two well established pharmacological models cause perturbations in the noise or stimulus-related signal similar to those found in schizophrenia (Behrendt, 2003; Behrendt and Young, 2004; Brenner et al, 2009; Canive et al, 1998; Dierks et al, 1995; Doheny et al, 2000; Ford et al, 2008; Fujisawa et al, 2004; Gaspar et al, 2009; Hall et al; Hall et al, 2009; Hong et al, 2004; Jensen and Lisman, 1996; Kessler and Kling, 1991; Kirino and Inoue, 1999; Kissler et al, 2000; Koukkou et al, 2000; Krause et al, 2003; Krishnan et al, 2009; Kwon et al, 1999; Leicht et al; Lifshitz et al, 1987; Light et al, 2006; Reinhart et al; Schellenberg and Schwarz, 1993; Spencer et al, 2004; Teale et al, 2008; Yamamoto, 1997). Additionally, inter-trial coherence, a measure for determining the trial to trial response consistency, was examined was analyzed in low and high frequency regions to determine whether or not a loss of response consistency is associated with changes in power.…”